Cargando…
Discovery of novel glioma serum biomarkers by proximity extension assay
BACKGROUND: Gliomas are among the most malignant tumors, with a very poor prognosis. Early diagnosis is highly desirable since it can help implement more effective treatments for smaller tumors, which have not yet extensively metastasized. Improving early diagnosis may facilitate access of patients...
Autores principales: | Ghorbani, Atefeh, Avery, Lisa M., Sohaei, Dorsa, Soosaipillai, Andrea, Richer, Maxime, Horbinski, Craig, McCortney, Katy, Xu, Wei, Diamandis, Eleftherios P., Prassas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037798/ https://www.ncbi.nlm.nih.gov/pubmed/36959545 http://dx.doi.org/10.1186/s12014-023-09400-5 |
Ejemplares similares
-
Tachykinins and the potential causal factors for post-COVID-19 condition
por: Janket, Sok-Ja, et al.
Publicado: (2023) -
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
por: Sohaei, Dorsa, et al.
Publicado: (2023) -
Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019) -
A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019) -
Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
por: Prassas, Ioannis, et al.
Publicado: (2012)